Depomed Inc. has announced that a clinical trial to evaluate a new delivery and absorption method for a medicine currently used to treat gastroesophageal reflux disorder (GERD) has been completed. Depomed hopes to translate these findings into an oral, controlled-released GERD medicine formula that will specifically treat nocturnal acid breakthrough. Nocturnal acid breakthrough is a condition that the drugmaker feels current therapies do not adequately treat.
Read moreI sometimes feel like this should be my opening line, an apology to the world for using medicine in my infant: Hi, my name is Jennifer... Read more »
One of our greatest food challenges has been to find sweets, especially candy and cupcakes that our son with acid reflux disease... Read more »
The presidential candidates are talking more and more about the high cost of medical care and offering their proposals. I hope the... Read more »
PAGER received a call from a reporter last Friday. The reporter talked to Jennifer Rackley and asked whether we think acid reflux is over... Read more »
My doctor has recommended that I have my hiatal hernia repaired. I am waiting to see a surgeon. Is this a good idea, and what should I ask... Read more »
Current GERD treatment includes one or a combination of the following therapies: Lifestyle modifications Antacid therapy H2 Receptor antagonists... Read more »
A new wireless pH-level monitor that helps doctors evaluate patients with hard-to-treat gastroesophageal reflux disorder (GERD) is currently being... Read more »
This is a study to evaluate the outcomes of using Protonix in children ages 1 year through 5 years with endoscopically proven gastroesophageal reflux... Read more »
This is a study to evaluate the outcomes of using Protonix in children ages 1 year through 5 years with endoscopically proven gastroesophageal reflux... Read more »
This discussion between doctors reviews questions to consider in treating GERD. Topics covered include alternative medications to proton-pump... Read more »